NCT07166016 is a NA clinical trial of Conservative in Hammertoe, sponsored by University of Texas Rio Grande Valley.

Who is sponsoring NCT07166016?

NCT07166016 is sponsored by University of Texas Rio Grande Valley.

What drugs are being tested in NCT07166016?

Interventions in NCT07166016: Conservative, Surgical.

Is NCT07166016 still recruiting?

NCT07166016 is currently recruiting now. Last updated 10 November 2025.

Last reviewed 2025-11-10 · How we verify

NCT07166016

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment Effects on Gait in Hammertoe Patients

Recruiting now NA Last updated 10 November 2025

What this trial tests

NA trial testing Conservative in Hammertoe in 30 participants. Currently enrolling.

Timeline

1 October 2025

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	University of Texas Rio Grande Valley
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 October 2025
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across United States

Drugs / interventions tested

Conservative
Surgical

Conditions studied

Hammertoe — all drugs for Hammertoe →

Sponsor

University of Texas Rio Grande Valley

Who can join

Eligibility, any sex, with Hammertoe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study looks at how hammertoe deformities affect foot pressure distribution and whether proper treatment can improve quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Conservative

Trials testing the same drug.

NCT03208153 — the Invasive and Conservative Strategies in Elderly Frail Patients With Non-STEMI · NA · completed

Other University of Texas Rio Grande Valley trials

Trials by the same sponsor.

NCT06516900 — Reducing Foot Pain and Peak Plantar Pressure in Patients With Foot Pain · NA · recruiting
NCT03436875 — Cardiometabolic and Mental Health in the RGV · withdrawn
NCT05851144 — South Texas Early Prevention Studies SNAP-Ed (STEPS SNAP-Ed) · NA · completed
NCT05589415 — Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI · NA · active not recruiting
NCT05589402 — Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI · Phase 1 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07166016 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Rio Grande Valley
Last refreshed: 10 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07166016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing